First China Pharmaceutical Group (FCPG) Stock Price, News & Analysis

Company Overview

First China Pharmaceutical Group (OTCMKTS:FCPG) is a China-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription and over-the-counter products. Headquartered in Wuhan, Hubei Province, the company operates through multiple domestic subsidiaries and production facilities certified under national Good Manufacturing Practices (GMP) standards. Since its establishment, First China Pharmaceutical Group has focused on building an integrated value chain from R&D to distribution within the People’s Republic of China.

The company’s product portfolio encompasses a range of injectable formulations—most notably vitamin and nutrient supplements such as vitamins B1, B6, B12 and C—in addition to central nervous system therapeutic agents. In its oral solid dosage segment, First China Pharmaceutical Group produces tablets and capsules in categories including analgesics, antipyretics and neuroprotective compounds. Research efforts are directed toward the development of new drug candidates targeting neuroprotection and metabolic health, supported by in-house laboratories and collaborative partnerships with academic institutions.

First China Pharmaceutical Group distributes its products through a network of hospitals, retail pharmacies and regional distributors across mainland China, with selected exports to neighboring Asian markets. The company’s governance is overseen by a board of directors and an executive management team experienced in pharmaceutical development, regulatory affairs and commercial operations. While detailed leadership biographies are not publicly disclosed, the firm emphasizes compliance with regulatory requirements and continuous improvement in manufacturing quality.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 15,858 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FCPG Stock Analysis - Frequently Asked Questions

How do I buy shares of First China Pharmaceutical Group?

Shares of FCPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of First China Pharmaceutical Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that First China Pharmaceutical Group investors own include SES AI (SES), American Heritage International (AHII), Affinity Networks (AFFN), Astera Labs (ALAB), Akoustis Technologies (AKTS) and American Battery Technology (ABAT).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Manufacturing
• Industry: Electronic Computer Manufacturing
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:FCPG
• CIK: 1432254
• Web: www.firstchinapharma.com
• Phone: +86-852-21381668
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A